Sterile Filtration Market Size (2023-2030)

The global sterile filtration was worth USD 4.9 billion in 2022 and is expected to reach USD 8.2 billion by 2030, and grows with a CAGR of 8.4% during the forecast period 2023-2030. 

Industry Overview:

Sterile filtration is a procedure of removing microorganisms from a fluid stream without adversely affecting the product. Sterile filtration is used for many applications like media with or without serum. Sterile filters are used in drug development and other biological processes where the contamination is high and has to be prevented. Sterile filters are small pores sized to develop the filtration process. Sterile filters are available in various forms like syringes, cartridges, disposable sterile filter systems, and capsules for the perfect filtration of liquid and gases. 

COVID-19 Impact on the Sterile Filtration Market:

The new infectious diseases, caused by the SARS-CoV-2, a novel coronavirus (COVID-19). The world pandemic has announced an emergency public health issue. The world economy has been severely affected and the structure of the market has changed. The pandemic has positively influenced the sterile filtration market and has surged the growth rate. Countries across the globe are extending and producing a vaccine for the novel coronavirus. 

For developing the vaccine, huge capital is being invested by government bodies and different filtration procedures are being used to develop and produce vaccines. The U.K government invested USD 82.0 million in research in coronavirus and vaccine development for the COVID-19. Researchers are working fiercely to test a wide variety of capable COVID-19 treatments. 

Market Drivers:

Factors involved in driving the sterile filtration market are the majority of the pharmaceutical, biotechnology, and other companies are highly spending on research and development activities. Growing chronic disease occurrences like diabetes, cancer, and heart problems with the rising patient population, and initial diagnosis of the disease and treatment stimulating the sterile filtration market growth. Approximately,55,122 new breast cancer cases were recorded in 2015, in the UK, as per Cancer Research. 

The growing demand for biopharmaceutical applications upsurges the market growth during the timeline period. Developing new medicines for treating common health issues that have contributed to the consumption of medicines, and these kinds of developments across the pharmaceutical sector intensify the sterile filtration market growth globally.

Market Restraints: Excessively high-cost sterile filtration process obstructs the market growth over the forthcoming years. 

STERILE FILTRATION MARKET REPORT COVERAGE:

Segment Analysis

The global sterile filtration market has been segmented and sub-segmented based on the product, application, membrane pore size, end-user, and membrane type.

Sterile Filtration Market - By Product

• Angioplasty Balloons

• Cartridge filters

• Capsule filters

• Membranes

• Syringe filters

• Bottle-top & table-top filtration systems

• Accessories

By product, most of the market share is held by the cartridge filters credited to the surging use of various numbers of filters for high procedures which requires more filtration area and less cost. The membrane filters product witnesses growth in the sterile filtration market as its applications for sterile filtration among both the pharmaceutical and biopharmaceutical labs is stimulating, and the kidney failure patient cases are surging, which fuels the sterile filtration market growth during the period.

Sterile Filtration Market - By Membrane Pore Size

• 2–0.22 µm

• 45 µm

• 1 µm

By pore size, 2-0.22 micron segment secures high potentiality. The segment growth ascribes to the growing need for the manufacturing of drugs and for eradicating microorganisms efficiently. The 45 microns segment will be the quickest growing segment owing to the growing use in research and analytical applications. 

Sterile Filtration Market - By Membrane Type

• Polyethersulfone (PES)

• Polyvinylidene difluoride (PVDF)

• Nylon

• Polytetrafluoroethylene (PTFE)

• Mixed cellulose ester & cellulose acetate (MCE & CA)

• Other materials

Based on the membrane type, the polyethersulfone (PES) segment held the largest share in 2019. The segment growth owes to the growing occurrence of atherosclerosis as an outcome of the growing frequency of obesity.

Sterile Filtration Market - By Application

• Fill-finish processes

• Buffer filtration & cell culture media preparation

• Bioburden reduction

• Water purification

• Air filtration

By application, the air filtration segment garner the highest revenue share in 2019 and continues to retain its dominance in the sterile filtration market by 2027. The growing adoption by the pharmaceuticals and active ingredients manufacturers for the dependable removal of particles and germs to stop contaminations and to confirm the purity of the product. The bioburden reduction segment will be the quick-growing segment in the sterile filtration market during the forecast period. The demand for monitoring bioburden to the processing of non-sterile bulk products is spurring to stop the excessive microbial load from reaching and fouling the sterilization. Also, it provides economic and equals the desired product quality swelling the sterile filtration market globally. 

Sterile Filtration Market - By End-User

• Pharmaceutical companies

• Biopharmaceutical companies

• Food & beverage companies

• CMOs & CROs

• Academic institutes & research laboratories

By end-user, pharmaceutical, and biopharmaceutical companies segment held a major share in terms of revenue and is in a position to grow with a CAGR of 4.8% during the forecast period. The usage of the sterile filtration process for addressing filtration and separation needs from research and development activities to initial stage product development propel the market's segment growth globally. CROs segment is planned to be the quickest-growing segment due to growing testing capacity and the existence absence of contaminating microorganisms with decreasing the turnover time and cross-contaminations threats. 

Sterile Filtration Market - By Regional Analysis:

• Regionally, North America accounts for the largest share in the sterile filtration market in 2019 ascribed to the existing presence of a large number of pharmaceutical and biotechnology, and food and beverages industries, and well-equipped healthcare infrastructure. The biopharmaceutical companies have spent around 79.6 USD billion for research and development activities, as per the Pharmaceutical Research and manufacturers of America, in 2018. The number of API manufacturing facilities and companies investing in research and development activities is increasing, which in turn boom the sterile filtration market growth in the region. The U.S is likely to hold the dominant position in the sterile filtration market. In the U.S., around 510 API facilities in 2019, as per the US Food and Drug Administration (US FDA). 

• The European sterile filtration market observed to have prominent growth during the forecast period due to the technological advancements in nanofibers, surging generic market, and large molecules and biologics production is spurring. 

• Asia-Pacific is measured to be the swiftest growing region globally, due to the growing demand for generic drugs and biosimilars, and considerable investments by biopharmaceutical industries and CMOs. The concentration on healthcare modernization is mounting and the need for low-cost medicines escalate the sterile filtration market growth during the period. 

• Latin America and the Middle East & African regions are expected to have a constant growth rate in the sterile filtration market throughout the foreseen period. 

Sterile Filtration Market - By Company Share

Major players operating in the sterile filtration market include

1. Merck KGaA (Germany)

2. Danaher Corporation (US)

3. Sartorius AG (Germany)

4. 3M (US)

5. Parker Hannifin Corporation (US)

6. Sterlitech Corporation (US)

7. Alfa Laval AB (Sweden)

8. Thermo Fisher Scientific (US).

Recent Developments

• On June 17, 2019, MilliporeSigma is scheduled to elevate the manufacture of filtration in New Hampshire, Jaffrey. To address the further requirements of the bioprocessing market, the approval process to expand the facility with extra cleanroom and lab. https://bioprocessintl.com/bioprocess-insider/upstream-downstream-processing/milliporesigma-plans-to-ramp-up-filtration-manufacture-in-nh/space over the next upcoming years.